These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 30928381)

  • 1. Activation of PSGR with β-ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocation.
    Xie H; Liu T; Chen J; Yang Z; Xu S; Fan Y; Zeng J; Chen Y; Ma Z; Gao Y; He D; Li L
    Cancer Lett; 2019 Jul; 453():193-205. PubMed ID: 30928381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of an olfactory receptor inhibits proliferation of prostate cancer cells.
    Neuhaus EM; Zhang W; Gelis L; Deng Y; Noldus J; Hatt H
    J Biol Chem; 2009 Jun; 284(24):16218-16225. PubMed ID: 19389702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative phosphoproteomics reveals the protein tyrosine kinase Pyk2 as a central effector of olfactory receptor signaling in prostate cancer cells.
    Wiese H; Gelis L; Wiese S; Reichenbach C; Jovancevic N; Osterloh M; Meyer HE; Neuhaus EM; Hatt HH; Radziwill G; Warscheid B
    Biochim Biophys Acta; 2015 Jun; 1854(6):632-40. PubMed ID: 25219547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals.
    Cui Y; Sun Y; Hu S; Luo J; Li L; Li X; Yeh S; Jin J; Chang C
    Oncogene; 2016 Nov; 35(47):6065-6076. PubMed ID: 27375022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression.
    Rodriguez M; Siwko S; Zeng L; Li J; Yi Z; Liu M
    Oncogene; 2016 Mar; 35(9):1153-62. PubMed ID: 26028029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
    Weng J; Ma W; Mitchell D; Zhang J; Liu M
    J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of OR51E1 causes growth suppression of human prostate cancer cells.
    Maßberg D; Jovancevic N; Offermann A; Simon A; Baniahmad A; Perner S; Pungsrinont T; Luko K; Philippou S; Ubrig B; Heiland M; Weber L; Altmüller J; Becker C; Gisselmann G; Gelis L; Hatt H
    Oncotarget; 2016 Jul; 7(30):48231-48249. PubMed ID: 27374083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancer.
    Narayanan R; Yepuru M; Szafran AT; Szwarc M; Bohl CE; Young NL; Miller DD; Mancini MA; Dalton JT
    Cancer Res; 2010 Jan; 70(2):842-51. PubMed ID: 20068182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth.
    Cha TL; Qiu L; Chen CT; Wen Y; Hung MC
    Cancer Res; 2005 Mar; 65(6):2287-95. PubMed ID: 15781642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
    Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
    Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization.
    Gioeli D; Black BE; Gordon V; Spencer A; Kesler CT; Eblen ST; Paschal BM; Weber MJ
    Mol Endocrinol; 2006 Mar; 20(3):503-15. PubMed ID: 16282370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structurally related odorant ligands of the olfactory receptor OR51E2 differentially promote metastasis emergence and tumor growth.
    Sanz G; Leray I; Grébert D; Antoine S; Acquistapace A; Muscat A; Boukadiri A; Mir LM
    Oncotarget; 2017 Jan; 8(3):4330-4341. PubMed ID: 28032594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
    Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASC-J9
    Lin W; Luo J; Sun Y; Lin C; Li G; Niu Y; Chang C
    Cancer Lett; 2018 Jul; 425():21-30. PubMed ID: 29425687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.
    Xu LL; Stackhouse BG; Florence K; Zhang W; Shanmugam N; Sesterhenn IA; Zou Z; Srikantan V; Augustus M; Roschke V; Carter K; McLeod DG; Moul JW; Soppett D; Srivastava S
    Cancer Res; 2000 Dec; 60(23):6568-72. PubMed ID: 11118034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
    Cao W; Li F; Yao J; Yu J
    BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of androgen receptor expression by Z-isochaihulactone mediated by the JNK signaling pathway and might be related to cytotoxicity in prostate cancer.
    Liu PY; Lin SZ; Sheu JJ; Lin CT; Lin PC; Chou YW; Huang MH; Chiou TW; Harn HJ
    Prostate; 2013 Apr; 73(5):531-41. PubMed ID: 23038474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of cancer cell invasiveness and metastasis emergence caused by olfactory receptor stimulation.
    Sanz G; Leray I; Dewaele A; Sobilo J; Lerondel S; Bouet S; Grébert D; Monnerie R; Pajot-Augy E; Mir LM
    PLoS One; 2014; 9(1):e85110. PubMed ID: 24416348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor (AR) degradation enhancer ASC-J9
    Cheng MA; Chou FJ; Wang K; Yang R; Ding J; Zhang Q; Li G; Yeh S; Xu D; Chang C
    Cancer Lett; 2018 Mar; 417():182-191. PubMed ID: 29203251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallein, a Gβγ subunit signalling inhibitor, inhibits metastatic spread of tumour cells expressing OR51E2 and exposed to its odorant ligand.
    Sanz G; Leray I; Muscat A; Acquistapace A; Cui T; Rivière J; Vincent-Naulleau S; Giandomenico V; Mir LM
    BMC Res Notes; 2017 Oct; 10(1):541. PubMed ID: 29084601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.